Shizim Group

Shizim Group is Israel’s leading integrated Life Sciences and Health Tech holding group.  Active in most areas of the biomedical ecosystem in Israel and around the world. As a private company, the Shizim Group is involved in:

• Finding and bringing breakthrough Medical Device and Digital Health technologies to market through innovation centers, support, mentoring and creating opportunities and alliances with global strategic partners.
• Offering full-service Contract Research Organization (CRO) to multinational Pharma and Medical Device companies.
• Marketing and distributing Pharmaceuticals and Medical Devices products of multinational corporates.
• Providing advanced education and training programs for medical professionals, investors and entrepreneurs in collaboration with the Technion.
• Medical Cannabis investment, R&D, global trade, education, medical farms, partnerships.

Shizim’s ecosystem is fully integrated to provide both services, commercial activities, global trade, investing opportunities and a variety of administrative and management services to Life Science projects.

Founded by Mr. Yossi Bornstein, former CEO of Bristol-Myers Squibb in Israel, in 2000, Shizim Group has a track record of finding opportunities that lead to success. Among its successes, is bringing one of its companies, Microbot Medical to a successful exit by listing the company in the NASADQ as a public company (NASDAQ: MBOT) and achieving FDA and CE approval for XACT Robotics, that is currently is in sales stage in the US.

Thanks to partnerships in the US, Europe, China, and other countries, Shizim offers new ideas and technologies, taking advantage of available grants and investment opportunities.  It’s a win-win situation for the host nation, investors and startups.